4 months Madrigal Q3 Earnings Beat, NASH Drug Sales Drive Top Line, Stock Up Zacks
MDGL stock is up as the company reports better-than-expected third-quarter results, beating earnings and revenue estimates, driven by strong Rezdiffra sales.
XMDGL stock is up as the company reports better-than-expected third-quarter results, beating earnings and revenue estimates, driven by strong Rezdiffra sales.
X